Table of Content

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product
2.4. Snippet by Indication
2.5. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Advancements in Diagnostic Technologies
3.1.1.2. Rising Prevalence of Cancer
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. High Costs of Diagnostic Procedures and Equipment
3.1.2.2. Limited Accessibility in Developing Regions
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Growth in Early Detection and Screening Programs
3.1.3.2. XX
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. South America
4.5.5. Middle East & Africa
4.6. Porter’s Five Forces Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. Cancer Diagnostics Market, By Product
5.1. Introduction
5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product
5.1.2. Market Attractiveness Index, By Product
5.2. Consumables*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. Antibodies
5.2.4. Kits & Reagents
5.2.5. Probes
5.2.6. Others
5.3. Instruments
5.3.1. Pathology-based Instruments
5.3.1.1. Tissue Processing Systems
5.3.1.2. Cell Processors
5.3.1.3. PCR Instruments
5.3.1.4. NGS Instruments
5.3.1.5. Microarrays
5.3.1.6. Others
5.4. Imaging Instruments
5.4.1.1. CT Systems
5.4.1.2. Ultrasound Systems
5.4.1.3. MRI Systems
5.4.1.4. Mammography Systems
5.4.1.5. Others
5.5. Biomarker-Based
5.6. Biopsy Instruments
6. Cancer Diagnostics Market, By Indication
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
6.1.2. Market Attractiveness Index, By Indication
6.2. Breast Cancer*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Colorectal Cancer
6.4. Cervical Cancer
6.5. Lung Cancer
6.6. Prostate Cancer
6.7. Skin Cancer
6.8. Blood Cancer
6.9. Kidney Cancer
6.10. Liver Cancer
6.11. Pancreatic Cancer
6.12. Ovarian Cancer
6.13. Others
7. Cancer Diagnostics Market, By Regional Market Analysis and Growth Opportunities
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
7.1.2. Market Attractiveness Index, By Region
7.2. North America
7.2.1. Introduction
7.2.2. Key Region-Specific Dynamics
7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.2.5.1. U.S.
7.2.5.2. Canada
7.2.5.3. Mexico
7.3. Europe
7.3.1. Introduction
7.3.2. Key Region-Specific Dynamics
7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.3.5.1. Germany
7.3.5.2. U.K.
7.3.5.3. France
7.3.5.4. Spain
7.3.5.5. Italy
7.3.5.6. Rest of Europe
7.4. South America
7.4.1. Introduction
7.4.2. Key Region-Specific Dynamics
7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.4.5.1. Brazil
7.4.5.2. Argentina
7.4.5.3. Rest of South America
7.5. Asia-Pacific
7.5.1. Introduction
7.5.2. Key Region-Specific Dynamics
7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
7.5.5.1. China
7.5.5.2. India
7.5.5.3. Japan
7.5.5.4. South Korea
7.5.5.5. Rest of Asia-Pacific
7.6. Middle East and Africa
7.6.1. Introduction
7.6.2. Key Region-Specific Dynamics
7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8. Competitive Landscape and Market Positioning
8.1. Competitive Overview and Key Market Players
8.2. Market Share Analysis and Positioning Matrix
8.3. Strategic Partnerships, Mergers & Acquisitions
8.4. Key Developments in Product Portfolios and Innovations
8.5. Company Benchmarking
9. Company Profiles
9.1. F. Hoffmann-La Roche Ltd*
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.2.1. Product Description
9.1.2.2. Product Key Performance Indicators (KPIs)
9.1.2.3. Historic and Forecasted Product Sales
9.1.2.4. Product Sales Volume
9.1.3. Financial Overview
9.1.3.1. Company Revenue
9.1.3.2. Geographical Revenue Shares
9.1.3.3. Revenue Forecasts
9.1.4. Key Developments
9.1.4.1. Mergers & Acquisitions
9.1.4.2. Key Product Development Activities
9.1.4.3. Regulatory Approvals, etc.
9.1.5. SWOT Analysis
9.2. Abbott.
9.3. Thermo Fisher Scientific Inc.
9.4. Siemens Healthcare Private Limited
9.5. GE HealthCare.
9.6. Illumina, Inc.
9.7. Bio-Rad Laboratories, Inc.
9.8. Hologic, Inc.
9.9. Koninklijke Philips N.V.,
9.10. BD.
9.11. QIAGEN
LIST NOT EXHAUSTIVE
10. Assumptions and Research Methodology
10.1. Data Collection Methods
10.2. Data Triangulation
10.3. Forecasting Techniques
10.4. Data Verification and Validation
11. Appendix
11.1. About Us and Services
11.2. Contact Us